DBD Stock Analysis: Buy, Sell, or Hold?
DBD - Diebold Nixdorf, Incorporated
$69.01
-0.34 (-0.49%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
12d
Get Alerted When DBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DBD shows positive signals but monitor for confirmation. Market pricing in 1.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: DBD shows positive signals but monitor for confirmation. Market pricing in 1.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$121.18
Based on 12.9% avg growth
INTRINSIC VALUE TODAY
$75.24
8.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DBD is currently trading at $69.01, which is considered fair relative to its 30-day fair value range of $67.05 to $70.18. The stock's valuation (Forward PE: 13.8) is in line with its historical norms (13.3). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, DBD is in a strong uptrend. The price is currently testing key support at $66.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $79.00 (+13.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DBD is in a strong uptrend. The price is currently testing key support at $66.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $79.00 (+13.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$67.05 -
$70.18
Company Quality Score
58/100
(HOLD)
Options IV Signal
36th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
72.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 36th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($79.00)
- BULLISH: Expecting earnings turnaround to 1.3% growth with 2.0% revenue growth
Fair Price Analysis
30-Day Fair Range
$67.05 -
$70.18
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$5.32
(7.7%)
Support & Resistance Levels
Support Level
$66.94
Resistance Level
$72.53
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
13.82
Wall Street Target
$79.00
(+13.9%)
Revenue Growth (YoY)
2.0%
Earnings Growth (YoY)
-17.2%
Profit Margin
1.4%
Valuation Premium vs History
+1.3% premium
PE vs Historical
13.8 vs 13.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$70.25
(+1%)
2-Year Target
$71.16
(+3%)
3-Year Target
$72.09
(+4%)
3-Yr Target (if PE normalizes)
(PE: 14→13)
PE COMPRESSION
$69.36
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 21.7%)
$201.48
(+191%)
Base:
(SPY PE: 13.8, Growth: 21.7%)
$124.90
(+80%)
Bear:
(PE: 11.8, Growth: 21.7%)
$106.17
(+53%)
📈
Valuation based on Current Earnings
Forward PE: 12.17 | Forward EPS (Implied): $5.70
Bull Case
$83.74
(+21%)
Analyst growth 15.0%, PE expands to 12.8
Base Case
$69.35
(0%)
Market implied 0.0%, PE stable at 12.2
Bear Case
$53.05
(-24%)
Severe decline -15.0%, PE contracts to 11.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 5:38 PM ET
Data refreshes hourly during market hours. Next update: 6:38 PM
Data refreshes hourly during market hours. Next update: 6:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Millstreet Capital Manag…
SELL
38963 shares
2025-09-18
Millstreet Capital Manag…
SELL
20000 shares
2025-09-16
Top Rated Software - Application Stocks
Top-rated stocks in Software - Application by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NOW
ServiceNow Inc |
STRONG BUY
47 analysts |
$208 | 56 HOLD |
|
TEAM
Atlassian Corp Plc |
STRONG BUY
33 analysts |
$235 | 57 HOLD |
|
HUBS
HubSpot Inc |
STRONG BUY
36 analysts |
$563 | 49 HOLD |
|
DDOG
Datadog Inc |
STRONG BUY
46 analysts |
$198 | 55 HOLD |
|
CRM
Salesforce.com Inc |
STRONG BUY
55 analysts |
$330 | 58 HOLD |
Advanced DBD Option Strategies
Professional options setups generated by AI based on today's DBD price and gamma walls.
